Upper GI bleeds: comorbidities more important than choice of anticoagulant

The type of oral anticoagulant – DOACs versus vitamin K antagonists (VKA) – has no influence on mortality following upper GI bleeding. A French study of 475 consecutive patients with upper GI bleeding before or during hospital admission found slightly more than half (54.6%) were on VKA antagonists as opposed to DOACs. Baseline characteristics were ...

Already a member?

Login to keep reading.

© 2021 the limbic